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The process of apoptosis in immune cells like mast cells is essential to regain homeostasis after an inﬂammatory response. The
intrinsic pathway of apoptosis is ultimately controlled by the pro-apoptotic Bcl-2 family members Bax and Bak, which upon
activation oligomerize to cause increased permeabilization of the mitochondria outer membrane leading to cell death. We
examinedtheroleofBaxandBakincytokine deprivation-inducedapoptosisinmastcellsusingconnectivetissue-likemastcells
andmucosal-likemast cellsderivedfrombax
 / ,bak
 / andbax
 / bak
 / mice.AlthoughbothBaxandBakwereexpressedat
readilydetectableproteinlevels,wefoundamajorroleforBaxinmediatingmastcellapoptosisinducedbycytokinedeprivation.
Weanalyzedcellviabilitybypropidiumiodide exclusion andﬂowcytometryafterdeprivationofvitalcytokinesforeachmast cell
population. Upon cytokine withdrawal, bak
 /  mast cells died at a similar rate as wild type, whereas bax
 /  and bax
 / bak
 / 
mast cells were partially or completely resistant to apoptosis, respectively. The total resistance seen in bax
 / bak
 /  mast cells
is comparable with mast cells deﬁcient of both pro-apoptotic Bim and Puma or mast cells overexpressing anti-apoptotic Bcl-2.
These results show that Bax has a predominant and Bak a minor role in cytokine deprivation-induced apoptosis in both
connective tissue-like and mucosal-like mast cells.
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Apoptosis is a genetically programmed mechanism for
induction of cell death. During an allergic inﬂammation, the
number of inﬂammatory immune cells including mast cells
increase at site. During the resolution phase and termination
of the inﬂammation, the process of apoptotic cell death is
critical to regain cellular and tissue homeostasis.
1
The intrinsic pathway of apoptosis is activated by stimuli
suchasgrowth factor deprivation or cell stress, including DNA
damage
2 and is tightly regulated by interactions between
pro- and anti-apoptotic members of the Bcl-2 family. The pro-
apoptotic BH3-only proteins comprising Bim, Bad, Noxa and
Puma are essential for initiation of apoptosis signaling. This
group of proteins activates the pro-apoptotic effector proteins
Bax and Bak indirectly by binding to the anti-apoptotic Bcl-2
family members (Bcl-2, Bcl-xL, Bcl-w, Mcl-1 and Bﬂ-1/A1) and
thereby titrate them away from Bax and Bak.
3 Whether the
activation of Bax and Bak occurs only indirectly is, however,
actively debated. A model of direct binding and activation of
Bax and Bak by the promiscuous BH3-only proteins Bid, Bim
and possibly Puma has also been suggested.
4–7 Activation of
Bax and Bak causes permeabilization of the mitochondrial
outer membrane, leading to release of cytochrome c, acti-
vation of caspase-9 and ultimately cell demolition.
8
Activation of mast cells by aggregation of the high afﬁnity
receptor for IgE, FceRI, is a key event in allergic reactions
leading to degranulation and release of pro-inﬂammatory
mediators. Connective tissue-like mast cells (CTLMC) but not
mucosal-like mast cells (MLMC) withstand the degranulation
process by activation-induced survival,
9 a process in which
the induction and function of the pro-survival protein A1 is
crucial.
10 In addition, other Bcl-2 family members such as the
pro-survival protein Bcl-XL but also the pro-apoptotic protein
Bim are upregulated by FceRI aggregation in mast cells.
11
Experiments with gene-targeted mice have shown that loss
ofeitherBim
11orPuma
12rendersmastcellspartiallyresistant
to cytokine deprivation-induced apoptosis. Experiments using
RNAi-mediated knockdown of gene expression showed
that the pro-survival Bcl-2 family member Mcl-1 is critical for
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13 In this study,
we have examined the role of the two pro-apoptotic effector
proteinsBaxandBakinmastcells,usingcellsdeﬁcientinBax,
Bak or both. We found that Bax has a more prominent role
than Bak in cytokine deprivation-induced apoptosis in both
CTLMC and MLMC.
Results
Characterization of in vitro-produced bax
 / bak
 / 
MLMC and CTLMC. To characterize bax
 / bak
 /  MLMC
and CTLMC, we examined their surface expression of Kit
and the high-afﬁnity IgE receptor FceRI. Immunoﬂuorescent
staining with speciﬁc Abs and ﬂow cytometric analysis
showed that mast cell populations lacking Bax and Bak
expressed levels of Kit and FceRI similar to their wt
counterpart (Figure 1a). We then compared the response
of wt and bax
 / bak
 /  MLMC and CTLMC, respectively,
to FceRI crosslinking measuring degranulation using a
b-hexosaminidase assay. In response to FceRI cross-linking
both wt and bax
 / bak
 /  MLMC and CTLMC, respectively,
responded by degranulation to a similar magnitude
(Figure 1b). These results show that the in vitro-produced
cells resembled primary mast cells, as conﬁrmed by toluidine
blue staining of cytoplasmic granules (data not shown),
expression of FceRI and c-Kit. In these respects, wt mast
cells and mast cells lacking Bax and Bak were
indistinguishable.
Figure 1 (a) Expression of the receptors Kit and FceRI on the cell surface of wt and bax
 / bak
 /  CTLMC and MLMC as examined by ﬂow cytometry. The colors black
andgrayrepresentswtandbax
 / bak
 / mastcells,respectively.Adashedlinerepresentsthestainingwithanisotype-matchedcontrolAb,whereastheﬁlledlinerepresents
staining with Abs for either Kit or FceRI. b-hexosaminidase release upon FceRI cross-linking of wt and bax
 / bak
 /  (dko) CTLMC and MLMC, respectively (b). One
representative of two independent experiments is presented
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Cell Death and DiseaseExpression of Bax and Bak in mast cells. Mast cells were
differentiated from mouse embryonic fetal livers. After 4
weeks in culture, pure cell cultures of CTLMC were obtained.
We then started by examining the protein and mRNA
expression of the two effector proteins Bax and Bak.
Analyzing mRNA expression of Bax and Bak in CTLMC by
RNase protection assay (RPA) revealed a more abundant
expression of bax compared with bak (Figure 2a). Moreover,
loss of either bax or bak did not cause any compensatory
alteration in the expression of the pro-survival genes bcl-w,
a1, bcl-xL or bcl-2 (Figure 2b). On protein level, both Bax and
Bak were detected in wild-type mast cells, although the levels
of Bak appeared to be lower than the levels of Bax.
Expectedly, no Bax or Bak protein was seen in mast cells
from respectively knock-out as well as from double-deﬁcient
mast cells (Figure 2c). Furthermore, we investigated
if activation of mast cells through FceRI not only alters
the expression of pro-survival proteins and BH3-only
proteins,
10,11 but also the effector proteins Bax and Bak.
We could observe a minor upregulating effect on Bak but no
prominent effect on Bax (Figure 2c), suggesting that IgE
receptor activation primarily controls mast cell survival by
regulating the levels and function of survival proteins and
BH3-only proteins and not the effector proteins.
Loss of Bax protects mast cells from cytokine
deprivation-induced apoptosis. Although both Bax and
Bak have been shown to have largely overlapping functions
in several cell types (e.g., lymphoid cells
14,15), it has also
been reported that one of these proteins can have the
dominant role. For example, Bax has the dominant role in
programmed cell death during spermatogenesis
16 and in
NGF deprivation-induced killing of neuronal cells,
17 whereas
Bak is essential for cell death in platelets.
18 To investigate
whether both Bax and Bak are necessary for mast cell
apoptosis we assessed cytokine deprivation-induced
apoptosis in mast cells deﬁcient in bax, bak or both
(bax
 / bak
 / ) and wild type. After 36h of starvation, more
than 60% of bax
 / , but less than 25% of the bak
 /  and wt
CTLMC were viable. The same pattern was seen in MLMC
although somewhat more rapid, with more than 60% viability
of bax
 /  mast cells and less than 25% of the bak
 /  or wt
already at 24h (Figure 3a and b). Notably, only combined
loss of both Bax and Bak conferred complete resistance to
cytokine deprivation, which demonstrates that Bak does
have a role in mast cell apoptosis, albeit a lesser one
compared with Bax.
Discussion
In the present study we have analyzed the individual and
combined roles of Bax and Bak in cytokine deprivation-
induced apoptosis in two mast cell sub-populations, MLMC
and CTLMC. We show that Bax has a more prominent role in
mast cell apoptosis than Bak, because mast cells lacking Bax
have an increased and prolonged survival compared with
Bak-deﬁcient mastcells.However, only combinedlossof both
Bak and Bax conferred complete resistance to cytokine
deprivation to a comparable extent as Bcl-2 overexpression
or combined loss of Puma and Bim (Figure 3c and d and
Alfredsson et al.
11 and Ekoff et al.
12). This shows that Bak
does have a function in mast cell apoptosis induced by
cytokine deprivation, albeit a lesser one compared with Bax.
Both Bax and Bak proteins are expressed in mast cells,
Figure 2 (a) Expressionof mRNAfor Bcl-2 memberswas analyzedusing RPA.
Extracted mRNA, 2mg per sample, was analyzed using a mAPO-2 multi-probe
template according to the RiboQuant System protocol. Presented is one
representative of two independent experiments. (b) The expression levels of pro-
survival bcl-2 family members were quantiﬁed in relation to control l32 and gapdh
using a phosphor-imager device. Data is presented as fold difference compared
with wild type of two different sets of RPA. (c) Both Bax and Bak proteins are
expressedinwtCTLMCandcontrolcells,mouseembryonicﬁbroblasts(MEF).Mast
cells were either resting or activated by IgE receptor cross-linking for 5h. One
representative of three independent experiments is presented
Figure 3 (a and b) Loss of Bax protects both CTLMC and MLMC from cytokine
deprivation-induced apoptosis more potently than loss of Bak. Mast cells from wt,
bax
 / , bak
 /  and bax
 / bak
 /  mice were deprived on cytokines for 86 or 40h,
respectively. Cell viability was analyzed by PI staining and FACS analysis.
Data are presented as mean (±S.E.M.) of three independent experiments.
(c and d) Survival of CTLMC and MLMC from wt, bim
 / puma
 /  and vav-bcl-2
transgenicmiceinabsenceofcytokineswasalsoanalyzedbyPIstainingandFACS
analysis. Data are presented as mean (±S.D.) of at least three independent
experiments. (e) A schematic picture illustrating the model of indirect activation of
apoptosisinvolvingthethreegroupsofBcl-2familyproteinscontrollingcellfate:pro-
apoptotic BH3-onlyproteins (Bimand Puma), anti-apoptotic Bcl-2-like proteins (Bcl-
2) and effector proteins (Bax/Bak)
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Cell Death and Diseasehowever, the level of Bax is higher than Bak, which could be a
plausible explanation for the increased survival in Bax-
deﬁcient mast cells when compared with those lacking Bak.
In addition, the augmented survival of mast cells deﬁcient in
Bak may be an effect of redundancy between the two effector
proteins.
MLMC and CTLMC overexpressing Bcl-2, or cells deﬁcient
in the two BH3-only proteins Bim and Puma, resemble Bak/Bax
double-deﬁcient mast cells in their profound resistance to
cytokine deprivation-induced apoptosis. By affecting critical
Bcl-2 family proteins in each of the three levels of the model
of indirect activation of apoptosis (Figure 3 and Willis et al.
3,
Chen et al.
19 and Willis et al.
20) cytokine deprivation-induced
apoptosisinmastcellscanbeinhibited.Accordingtothismodel,
pro-apoptotic BH3-only proteins activate Bak and Bax only by
neutralizing pro-survival proteins such as Bcl-2, and not by
direct interaction between Bak/Bax and the BH3-only proteins
(Figure 3e). Our previous ﬁndings together with the data
presented here indicate that the two BH3-only proteins Bim
and Puma are essential for cytokine deprivation-induced
apoptosis in mast cells and that Bim and Puma together
interact with and neutralize all pro-survival proteins involved.
Furthermore, overexpressing Bcl-2 in mast cells is sufﬁcient
for profound resistance to cytokine deprivation-induced
apoptosis, suggesting that Bcl-2 keeps both effector proteins
in check. In mouse embryo ﬁbroblasts, Bak is restrained by
the pro-survival proteins Mcl-1 and Bcl-xL, but not Bcl-2,
20
whereas Bax is probably inhibited by the pro-survival proteins
Bcl-2, Bcl-w, Bcl-xL and Mcl-1.
3 Our data about Bax having a
more prominent role compared with Bak in cytokine depriva-
tion-induced apoptosis in mast cells might conduce to explain
why mast cells overexpressing Bcl-2 are totally resistant to
apoptosis.
The data presented here are in accordance with a previous
report in which IL-3 derived bone marrow mast cells from
bax
 /  mice were shown to have an increased survival upon
cytokine deprivation.
21 They also found an increase in mast
cell numbers in the stomach mucosa and a minor increase of
mastcellsinbackskinofbax
 / micecomparedwithwild-type
mice. This indicates that for mast cell homeostasis, Bax has a
more prominent role in mucosal mast cells compared with
connective tissue mast cells. By contrast, our in vitro data
reveal no difference in the importance of Bax for the induction
of apoptosis in MLMC and CTLMC, suggesting other
additional mechanisms in vivo.
Mast cells are implicated in a number of different diseases
wherereducingtheirnumberswouldbebeneﬁcialforreducing
the severity of the symptoms, and in the best scenario
contribute to cure the disease. These diseases include mast
cell-driven diseases like mastocytosis
22 and allergic reac-
tions, but also chronic inﬂammations such as atherosclerosis
and autoimmune diseases
23–25 and tumors.
26
In summary, in this paper we have analyzed the roles of the
two pro-apoptotic proteins Bak and Bax in cytokine depriva-
tion-induced apoptosis of CTLMC and MLMC. We report that
Bax has a more prominent role than Bak in this process;
however, both are needed because only bax
 / bak
 /  cells
were totally resistant to cytokine deprivation-induced apopto-
sis.Ourresultscontributetotheworkofdecipheringtheroleof
theBcl-2familymembersintheregulationofmastcellsurvival
and apoptosis and have implications for designing new
therapeutic protocols for treatment of mast cell-associated
disorders.
Materials and Methods
Mice and cell cultures. The generation and genotyping of bax
 / , bak
 / ,
bax
 / bak
 /  and bim
 / puma
 /  as well as vav-bcl-2-transgenic mice have
been described previously.
14,16 Fetal liver-derived mast cells from wt C57BL/6 mice
or mice of bax
 / , bak
 /  and bax
 / bak
 /  were differentiated into CTLMC or
MLMC using previously described protocols.
9 Brieﬂy, fetal livers from E14 mouse
embryos were dissected and kept on ice in KDS BSS þ 10% FBS. Livers were
homogenized, cells washed in PBS and cultured at 3 10
5 cells per ml under
conditions promoting the development of CTLMC (RPMI-1640 supplemented with
25ng/mlrSCFand1ng/mlrIL-4(PeprotechECLtd,RockyHill,NJ,USA))orMLMC
(DMEM supplemented with 25ng/ml rSCF, 100U/ml IL-3 (cell supernatant from
X63/0 hybridoma stably transfected with an IL-3 expression vector), 5ng/ml rIL-9 and
1ng/mlrTGF-b1 (both from R&D systems, Minneapolis, MN, USA)) respectively. All
cells were cultured 4 weeks before being used. Similarly, bone marrow cells from
wild type, vav-bcl-2-transgenic and bim
 / puma
 /  were differentiated into
CTLMC and MLMC using protocols described.
9 All experiments with animals were
performed according to the guidelines of the Royal Melbourne Hospital Research
FoundationAnimalEthicsCommitteeortheAnimalEthicsCommitteeinStockholm.
Detection of Kit and FceRI on mast cell surface. The cells were
examined by ﬂow cytometric analysis for expression of Kit and FceRI, using FITC-
anti-mouse CD117 (Kit) mAb 2B8 or FITC-conjugated rat IgG2b isotype control
(both from BD Pharmingen, San Diego, CA, USA), FITC-conjugated anti-mouse
FceRI mAb MAR-1, or FITC-conjugated Armenian hamster IgG isotype control
(both from eBioscience, Hatﬁeld, UK).
In vitro cell activation by IgE receptor crosslinking. CTLMCs and
MLMCs were suspended at 5 10
5 cells per ml. For FceRI stimulation, mast cells
were sensitized for 90minusing a monoclonal murine IgE anti-TNP antibody(IgE1-b4,
ATCC), supplied as a 15% hybridoma supernatant. The cells were washed twice
in PBS and then challenged with 10ng/ml TNP-BSA (coupling ratio 9, Biosearch
Technologies Inc, San Francisco, CA, USA) for the time periods indicated. Cell
viability was determined by propidium iodide exclusion (5mg/ml, Sigma-Aldrich,
Steinheim, Germany) and ﬂow cytometric analysis using a FACScan (Becton
Dickinson, Franklin Lakes, NJ, USA).
9
N-acetyl-b-D-hexosaminidase release assay. Cells to be used in the
N-acetyl-b-D-hexosaminidase assay were resuspended in RPMI 1640 medium
supplementedwith0.2%BSA(Sigma-Aldrich)beforethecellswereactivatedbyIgE
receptor crosslinking. For detection of the granular enzyme b-hexosaminidase, an
enzymatic colorimetric assay was used as described previously.
10 Brieﬂy, 60mlo f
supernatant was transferred to a 96-well plate and mixed with an equal volume of
substrate solution (7.5mM p-nitrophenyl-N-acetyl-b-D-glucosaminide dissolved in
80mM citricacid,pH 4.5). Themixturewas incubatedon a rocker platformfor 2h at
371C. After incubation, 120ml of glycine (0.2M, pH 10.7) was added to each well,
and the absorbance at 405 and 490nm was measured using an Emax Precision
Microplate Reader (Molecular Devices, Sunnyvale, CA, USA).
Western blot analysis. CTLMCs (1.5 10
6 cells) were activated by IgE
receptor cross-linking and harvested after 5h, washed in ice-coldPBS, and lysed in
RIPA buffer (50mM Tris-HCl pH 7.4, 150mM NaCl, 1% NP-40, 0.5% Sodium
deoxycholate, 0.1% SDS) supplemented with protease inhibitors (Roche,
Mannheim, Germany). Lysates from mouse embryonic ﬁbroblasts (MEF) were
included as control for expression of Bax and Bak. Protein, 40mg, was dissolved in
SDS loading buffer and size-fractionated on 12% Tris-glycine gels (Invitrogen,
Carlsbad, CA, USA). Western blotting was performed using polyclonal rabbit anti-
Bak antibodies (1:1000; Sigma-Aldrich) or a monoclonal mouse anti-Bax antibody
(1:1000; Sigma-Aldrich), followed by horseradish peroxidase-conjugated sheep
anti-rabbitIgG or sheep anti-mouse IgG antibodies (1:5000; Chemicon, Temecula,
CA, USA). Bound antibodies were visualized by enhanced chemoluminoscence
(ECL) and exposure to Hybond ECL ﬁlm (Amersham Biosciences, Uppsala,
Sweden).
Bax dependency in mast cell apoptosis
M Karlberg et al
4
Cell Death and DiseaseRNase protection assay. Total RNA was extracted using TriPure isolation
reagent (Roche). mRNA, 2mg per sample was analyzed by RPA according to the
RiboQuant System (Becton Dickinson) protocol, using a mAPO-2 multi-probe
template (Becton Dickinson). The gel was dried and exposed on Kodak ﬁlm
(Eastman Kodak Company, Stockholm, Sweden) with intensifying screens at
 701C.Quantiﬁcationwasperformedusingaphospho-imagerdeviceandMacBas
V2.2 Software (Fuji Photo Film, Co. Ltd., Stockholm, Sweden).
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